Asia Pacific Bioadhesive Market Size:
The Asia Pacific Bioadhesive Market is expected to grow from US$350.334 million in 2025 to US$522.599 million in 2030, at a CAGR of 8.33%.
Biological surfaces can be adhered to using bioadhesives, which are compounds with adhesive properties found in naturally occurring polymeric materials. In order to make glue, biological intermediates such as starch, cellulose, or gelatin are utilized. In clinical settings, bioadhesives have proven to be superior to tissue adhesives, hemostats, and tissue sealants. Due to the inherent stickiness, the applications have been broadened to include the fixation of medical devices as well as functional wound dressing and factor delivery vehicles.
Asia Pacific Bioadhesive Market Growth Drivers:
- Rising environmental concerns and industrialization are expected to boost the growth of the bioadhesives market in the Asia Pacific Region
Rising environmental concerns will be the main factor driving the growth of the worldwide bioadhesives market. Many countries now accept bio-based products as legal requirements for a variety of uses. In order to ensure safety and prevent health problems and hazards brought on by VOC emissions from synthetic or petro-based adhesives, bio-products are also prioritized by international adhesive manufacturers. As a result, it will stimulate the market for bioadhesives on a global scale.
The vast range of uses for bioadhesives in construction, personal care, paper & packaging, medical, and other industries will fuel the expansion of the worldwide bioadhesives market during the study period. It is estimated that the Asia-Pacific bioadhesives market will expand as a result of the region's high population and rapid development. Additionally, rising urbanization spending is anticipated to help the global bioadhesives market over the course of the forecast year.
Asia Pacific Bioadhesive Market Product Offerings:
- PROLOC Bioadhesive: Henkel's patented PROLOC bioadhesive technology is an improved method for delivering therapeutic drugs locally and across mucosal membranes at different absorption locations. While still being gentle on the mucosa, PROLOC bioadhesive nanoparticles offer improved bioadhesive characteristics and the potential for larger medication loading. A patented technique using USP-grade amylopectin (waxy maize) and USP-grade carbomer is used to create PROLOC bioadhesive gels. Carbomers are bioadhesive polymers that are frequently found in skin care products and are perfect for targeted and regulated drug administration. The PROLOC system can be used as a powder, cast as a film, or crushed as a tablet. A number of clinical experiments have been carried out to show that the PROLOC technology can successfully transport medications across the mucosa or for local therapy.
- GantrezTM: The synthetic, alternating copolymers of methyl vinyl ether (mve) and maleic anhydride known as GantrezTM, a polymer comes in a variety of molecular weights. Despite not being directly applicable to oral care goods, anhydride polymers (and grades) are utilized as the basis polymer to create polymer salts that are applied as bioadhesives in denture adhesive applications. The anhydride side-chain hydrolyzes when gantrezTM polymer anhydrides are dispersed in water, resulting in free diacid solutions that are immediately usable in oral care products. As Gantrez's polymers, GantrezTM polymer diacids are offered. Denture adhesive polymers are synthesized as part of the application.
Asia Pacific Bioadhesive Market Segmentation:
- By Source
- By Industry Vertical
- Packaging
- Construction
- Healthcare
- Consumer Goods
- Others
- By Country
- India
- China
- Japan
- South Korea
- Taiwan
- Thailand
- Indonesia
- Others